We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Transparent Corporation of Japan, and Molecular Response Sign Key Collaboration and Supply Agreement

News   Mar 27, 2012

 
Transparent Corporation of Japan, and Molecular Response Sign Key Collaboration and Supply Agreement
 
 
 

RELATED ARTICLES

Novel Binding Site for Anti-cancer Drugs

News

A research team at the Medical University of South Carolina (MUSC) has discovered a new mechanism for a class of anti-cancer drugs known as E1 inhibitors.

READ MORE

AI Predicts Survival of Ovarian Cancer Patients

News

New machine learning software can forecast the survival rates and response to treatments of patients with ovarian cancer.

READ MORE

Resistant Melanoma Sensitized to Cytotoxic T Cells with BRAF-targeting

News

BRAF-targeted therapies render resistant melanoma more sensitive to the attack of killer T cells. The findings pave the way in developing therapy for patients that have become resistant to BRAF inhibitors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE